Tag: Cancer: Misc.
68Ga-Somatostatin Analog PET-CT Linked to Reduced Costs
Reduced costs versus 111In-octreotide scintigraphy for imaging neuroendocrine tumors
ASCO Addresses Cancer Drug Pricing
New drugs routinely cost more than $100K per year; prices on many existing treatments continue to rise
More Patients Enrolled in Cancer Trials Under ACA
Insurer approval rates rose from ~85 percent before Affordable Care Act to ~95 percent after
NCI-Designated Care Often Excluded in Narrow Health Plans
Oncologists affiliated with NCI-Designated or NCCN Cancer Centers more likely excluded in narrow plans
Single-Dose PCV13 Immunogenic, Safe in Pediatric Oncology
After vaccination, ≥70 percent had protective antibody titers for S. pneumoniae serotypes
Distress Screening Tied to Fewer ER Visits for Cancer Patients
Lower risk ratios for ER use and hospitalization when cancer program adherence documented
Wait-and-Scan Strategy Feasible for Head, Neck Paraganglioma
Large group of tumors found not to grow, although they did elicit complications
Empowerment Linked to HRQoL in Teen, Young Adult CA Survivors
Empowerment associated with physical, psychological, social, religious, and total HRQoL
Rivaroxaban OK for Stroke Prevention in Cancer Patients
Safety, efficacy in cancer patients similar to the general population
June 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for June 2017. This roundup includes...
